Global Leader in Drug Name Development

The Global Leader in

Drug Name Development

In the pharmaceutical and biotech industries, a drug’s name is more than just a label—it’s a critical asset. A well-crafted name must be distinctive, memorable, regulatory-compliant, and globally viable. Choosing the right naming agency can mean the difference between a seamless approval process and costly delays.

👉 Schedule your free consultation now!




    👉 Schedule your free consultation now!




      The Brand Institute Advantage

      Industry-Leading Expertise

      • 30+ years developing successful brands names.
      • 14 consecutive years leading global drug name approvals.

      Regulatory Excellence

      • Regulatory subsidiary (Drug Safety Institute) with ex-naming-officials from FDA, EMA, Health Canada, etc.
      • Co-authored the name review guidelines while with their former, respective agencies.

      Proven Success

      • Expert creative, trademark and market research services.
      • Ongoing support with no hidden fees.

      Our Regulatory Advantage

      Former Naming Officials

      • Former FDA, EMA, Health Canada, AMA, and WHO naming leaders personally involved in every project.

      Fully Compliant Methodology

      • Continuously updated per global health agency guidance and leadership interactions.

      Tiered Name Recommendations

      • Regulatory-based safety research helps teams balance risk and commercial appeal.

      Why Choose Brand Institute?

      • Our people, our process, and a proven track record of exceptional results.
      • Partnered with over 1,500 on over 5,000 healthcare-related names.
      • Expertise in all disciplines required to bring a great brand to market.

      Discover How We Can Help!